Four days before an FDA panel endorsed the Novavax vaccine 21-0, the biotech company informed the FDA of changes to its manufacturing process, according to CNBC.
Read the full post on Becker's Hospital Review - Healthcare News
Novavax’s COVID-19 vaccine could be postponed
